Various toxicities: 10 case reports

    This is a preview of subscription content, access via your institution.


    1. Leist T, et al. Long-term safety data from the cladribine tablets clinical development program in multiple sclerosis. Multiple Sclerosis and Related Disorders 46: 1-8, Nov 2020. Available from: URL:

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Cladribine. Reactions Weekly 1841, 79 (2021).

    Download citation